Direct anti-atherosclerosis-related effects of garlic. 1995

A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
Institute of Experimental Cardiology, Russian Academy of Medical Sciences, Moscow.

Direct anti-atherosclerosis-related effects of garlic were studied using cell culture. An aqueous extract from garlic powder (GPE) was added to smooth muscle cells cultured from atherosclerotic plaques of human aorta. During a 24-hour incubation, GPE significantly reduced the level of cholesteryl esters and free cholesterol in these cultured cells and inhibited their proliferative activity. In addition, GPE significantly reduced cholesterol accumulation and inhibited cell proliferation stimulated by blood serum taken from patients with angiographically assessed coronary atherosclerosis, i.e. GPE reduced atherogenic manifestations of patients' serum. Garlic effect on blood atherogenicity of patients with coronary atherosclerosis has also been studied ex vivo. Following a 24-hour incubation with cultured cells, patients' blood serum caused an increase of total cell cholesterol. Blood serum taken 2 hours after an oral administration of 300 mg garlic powder tablet caused substantially less cholesterol accumulation in cultured cells. This suggests that garlic powder manifests direct anti-atherogenic-related action not only in vitro but also in vivo.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005737 Garlic A species of Allium used as a spice (SPICES) and traditional remedy. It contains alliin lyase and alliin, which is converted by alliin lyase to allicin, the pungent ingredient responsible for the aroma of fresh cut garlic. Allium sativum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
January 1997, Nutrition (Burbank, Los Angeles County, Calif.),
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
January 1985, Ugeskrift for laeger,
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
October 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology,
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
December 1997, Phytomedicine : international journal of phytotherapy and phytopharmacology,
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
October 1981, Indian journal of pathology & microbiology,
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
January 2015, Journal of immunology research,
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
May 1994, Arzneimittel-Forschung,
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
May 1979, Japanese heart journal,
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
September 1976, Lancet (London, England),
A N Orekhov, and V V Tertov, and I A Sobenin, and E M Pivovarova
January 2018, Endocrine, metabolic & immune disorders drug targets,
Copied contents to your clipboard!